高级搜索
张伟硕, 高春, 房龙. 2型糖尿病和血小板计数在原发性肝癌患者中的关系研究[J]. 肿瘤防治研究, 2016, 43(5): 371-374. DOI: 10.3971/j.issn.1000-8578.2016.05.011
引用本文: 张伟硕, 高春, 房龙. 2型糖尿病和血小板计数在原发性肝癌患者中的关系研究[J]. 肿瘤防治研究, 2016, 43(5): 371-374. DOI: 10.3971/j.issn.1000-8578.2016.05.011
ZHANG Weishuo, GAO Chun, FANG Long. Association Between Type-2 Diabetes Mellitus and Platelet Count in Patients with Primary Liver Cancers[J]. Cancer Research on Prevention and Treatment, 2016, 43(5): 371-374. DOI: 10.3971/j.issn.1000-8578.2016.05.011
Citation: ZHANG Weishuo, GAO Chun, FANG Long. Association Between Type-2 Diabetes Mellitus and Platelet Count in Patients with Primary Liver Cancers[J]. Cancer Research on Prevention and Treatment, 2016, 43(5): 371-374. DOI: 10.3971/j.issn.1000-8578.2016.05.011

2型糖尿病和血小板计数在原发性肝癌患者中的关系研究

Association Between Type-2 Diabetes Mellitus and Platelet Count in Patients with Primary Liver Cancers

  • 摘要:
    目的  探讨2型糖尿病和血小板计数在原发性肝癌患者中的关系。
    方法  采用横断面研究,按照诊断标准、纳入和排除标准,研究纳入2003年1月至2012年4月在中日友好医院住院且以“原发性肝癌”作为主要诊断的患者375例。分析入选患者的人口统计学、临床、生化、代谢等资料,二元非条件Logistic回归分析研究2型糖尿病和血小板计数在原发性肝癌患者中的关系。
    结果  375例患者中,63例(16.8%)合并2型糖尿病,患者的平均白细胞计数(4.13±2.49)×109/L,血红蛋白定量(132.5±23.8)g/L,血小板计数的中位数和四分位数间距130/(85~189)×109/L,国际标准化比值(1.20±0.27)。两组比较的结果提示,血小板计数113/(64~157)×109/L vs. 139/(89~192)×109/L, P=0.020在两组人群中差异存在统计学意义。多因素分析的结果显示,在控制年龄、乙肝感染、血红蛋白定量和INR等情况下,血小板计数不是原发性肝癌合并2型糖尿病患者的独立相关因素,OR值为0.999,95%CI: 0.995~1.003(P=0.505)。
    结论  原发性肝癌合并2型糖尿病患者的血小板计数明显低于肝癌不合并糖尿病患者,Logistic回归分析归因于其他因素的作用。

     

    Abstract:
    Objective  To determine the association between type-2 diabetes mellitus (DM) and platelet count in patients with primary liver cancers (PLC).
    Methods  We included 375 patients with a hospital discharge diagnosis of PLC treated in the China-Japan Friendship Hospital from January 2003 to April 2012 in this investigation, according to the diagnostic criteria, inclusion and exclusion criteria. The demographic, clinical, biochemical and metabolic data were analyzed; and the multivariate logistic regression model was used to determine the association between DM and platelet count in PLC patients.
    Results  Of the total 375 patients, 63 (16.8%) cases were diagnosed with DM, the mean neutrophil count was (4.13±2.49)×109/L, the mean hemoglobin was (132.5±23.8)g/L, the median/interquartile range of platelet count was 130/(85-189)×109/L and the mean international normalized ratio (INR) level was (1.20±0.27). A statistical difference was found by univariate analysis for the platelet count 113/ (64-157)×109/L vs. 139/(89-192)×109/L, P=0.020, however, no statistical difference (OR=0.999, 95%CI: 0.995-1.003, P=0.505) was found by the multivariate analysis, after controlling the age, HBV infection, hemoglobin and INR.
    Conclusion  PLC patients with type-2 DM have obviously decreased platelet count, compared with those without DM, which is modified by other factors.

     

/

返回文章
返回